The Ensign Group, Inc. (ENSG)
NEUTRALFundamental
68
Precio
$178.44
Capitalización Bursátil
$10.57B
Parte 1 · Cuánto vale la empresa
Resumen
The Ensign Group, Inc. provides skilled nursing, senior living, and rehabilitative services. It operates through two segments: Skilled Services and Standard Bearer. The Skilled Services segment provides short and long-term nursing care services for patients with chronic conditions, prolonged illness, and the elderly; specialty care, such as on-site dialysis, ventilator care, cardiac, and pulmonary management; and standard services, such as room and board, special nutritional programs, social services, recreational activities, entertainment, and other services. The Standard Bearer segment leases post-acute care properties to healthcare operators. In addition, the company operates senior living units; and provides ancillary services consisting of digital x-ray, ultrasound, electrocardiograms, sub-acute services, dialysis, respiratory, and long-term care pharmacy and patient transportation to people in their homes or at long-term care facilities, as well as mobile diagnostics. The company operates healthcare facilities in Alabama, Alaska, Arizona, Colorado, Idaho, Iowa, Kansas, Oregon, Nebraska, Nevada, South Carolina, Tennessee, Texas, Utah, Washington, and Wisconsin. The company was incorporated in 1999 and is based in San Juan Capistrano, California.
No editorial profile for this company yet
Direct competitors
Who this company fights with for the same customers
No editorial profile for this company yet
No competitor list for this company yet.
Balance y Liquidez
Ingresos
$5.46B
Últimos 12 meses (hasta 30/6/2026)
Beneficio Neto
$379M
Últimos 12 meses (hasta 30/6/2026)
Flujo de Caja Libre
-
Patrimonio Neto Total
$2.23B
Pasivo Total
$3.23B
Ratio de Liquidez
1.21
Cobertura de Intereses
59.99
Deuda/EBITDA
4.25
Beneficio Por Acción
Ingresos y Beneficio Neto
Flujo de Caja Libre
Desglose de Ingresos
Estado histórico
Márgenes en el tiempo
La deuda en el tiempo
Cuánto pesa la deuda
Cuadro de crecimiento
Crecimiento — Ingresos
Estimación de Valor Justo
Valor Justo
$154.78
Precio Actual
$178.44
Margen de Seguridad
-15.3%
Rango de Valor Justo
$100.60 - $208.95
Métodos de Estimación
Métricas de Valoración
Ratio P/E
28.11
ROE
15.4%
Ratio P/B
4.28
P/FCF
-
Margen Bruto
20.3%
ROIC
7.6%
Radar de Rentabilidad
Value Creation (Economic Moat)
ROIC
7.6%
WACC
6.8%
ROIC − WACC
+0.8 pp
ROIC is roughly in line with the cost of capital — the company is barely covering its capital cost.
Criterios de Análisis Fundamental
Superado (17)
- EPS shows upward trend
- EPS CAGR 8.64%
- Price CAGR 24.07%
- ROIC 7.6%
- Debt/Equity ratio
- Operating Margin 8.6%
- Current Ratio
- Interest Coverage
- Debt/EBITDA
- Return on Tangible Assets
- Low reliance on intangibles
- ROE 16.5%
- Revenue Growth 5Y 16.1%
- Analyst Consensus 83% Buy
- Earnings Quality (OCF/NI) 1.61
- Share Dilution 1.2%
- Piotroski F-Score 5/9
Fallido (7)
- Gross Margin 20.3%
- P/B Ratio 4.28
- Price below Graham Number
- DCF valuation (Overvalued)
- Earnings Surprise avg 0.7%
- PEG Ratio 2.02
- Net Margin Trend 6.9% vs 7.0%
No disponible (4)
- P/FCF NaN
- Dividend Payout NaN%
- Positive Free Cash Flow
- CapEx intensity
Piotroski F-Score
Señales mixtas: algunas áreas requieren atención
Calidad de los Beneficios
Alta calidad: beneficios respaldados por efectivo
Dilución de Acciones
El número de acciones es estable
Gobernanza
Equipo Directivo
| Nombre | Cargo | Edad |
|---|---|---|
| Mr. Barry R. Port | CEO & Chairman of the Board | 51 |
| Mr. Spencer W. Burton | President & COO | 46 |
| Ms. Suzanne D. Snapper CPA | CFO, Executive VP & Director | 51 |
| Mr. Chad A. Keetch J.D. | Chief Investment Officer, Executive VP & Secretary | 47 |
| Ms. Beverly B. Wittekind | Executive VP & General Counsel | 60 |
| Kevin Reese | President of Keystone Healthcare Inc | - |
Riesgo de Auditoría
7
Riesgo del Consejo
5
Riesgo de Compensación
7
Riesgo de Derechos del Accionista
2
Parte 2 · El precio y el momento de entrar
Esta parte no sirve para saber si la empresa vale: sirve para elegir cuándo comprarla, una vez que los fundamentales te han convencido. Dentro: análisis técnico, potencial, caídas históricas, exposición gamma.
Latest News
Recent headlines for ENSG, sourced from Markets Gazette.